Human papillomavirus (HPV) variants associated with head and neck cancer generally induce a robust immune response. Despite the establishment of such an inflammatory microenvironment, HPV is able to persist and promote malignant transformation. The PD-1:PD-L1 immune checkpoint may play a critical role in the creation of an immunoprivileged site for viral persistence and the subsequent development of cancer. © 2013 Landes Bioscience.
CITATION STYLE
Pai, S. I. (2013). Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma. OncoImmunology, 2(5). https://doi.org/10.4161/onci.24065
Mendeley helps you to discover research relevant for your work.